Jian Yu
24Patents
5h-index
31Co-inventors
65Inventor score
Filing activity: Apr 13, 2007 → Mar 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9758591B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 12 | Active |
| US7700339B2 | Gene defects and mutant ALK kinase in human solid tumors | Physics | 6 | Active |
| US8168383B2 | Gene defects and mutant ALK kinase in human solid tumors | Emerging Cross-Sectional Technologies | 5 | Active |
| US8288102B2 | Gene defects and mutant ALK kinase in human solid tumors | Physics | 5 | Active |
| US8377642B2 | Gene defects and mutant ALK kinase in human solid tumors | Physics | 5 | Active |
| US8481279B2 | Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase | Emerging Cross-Sectional Technologies | 5 | Active |
| US10344096B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 4 | Active |
| US11312787B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 2 | Active |
| US8486645B2 | Gene defects and mutant ALK kinase in human solid tumors | Emerging Cross-Sectional Technologies | 2 | Active |
| US9587012B2 | Bispecific HIV-1 neutralizing antibodies | Chemistry; Metallurgy | 1 | Active |
| US10913798B2 | Modulators of ROR1-ROR2 binding | Physics | 1 | Active |
| US9884905B2 | Bispecific HIV-1 neutralizing antibodies | Chemistry; Metallurgy | 1 | Active |
| US9988688B2 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | Physics | 1 | Active |
| US10308707B2 | Bispecific HIV-1-neutralizing antibodies | Chemistry; Metallurgy | 1 | Active |
| US12162950B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 0 | Active |
| US7977462B2 | Tyrosine phosphorylation sites | Chemistry; Metallurgy | 0 | Active |
| US10000568B2 | Compositions and methods for detecting EGFR in cancer | Physics | 0 | Active |
| US10870892B2 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | Physics | 0 | Active |
| US12098187B2 | Bispecific HIV-1-neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
| US10955416B2 | Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US12286480B2 | Modulators of ROR1-ROR2 binding | Physics | 0 | Active |
| US9523130B2 | Methods of treating non-small cell lung carcinoma (NSCLC) | Physics | 0 | Active |
| US10654943B2 | Tri-specific antibodies for HIV therapy | Chemistry; Metallurgy | 0 | Active |
| US11505833B2 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.